DOCSLIB.ORG

Portal Procedure Code Portal Procedure Name Portal Package Amount M1.1 Medical Management of Acute Severe Asthma with Acute

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Portal Portal Procedure Portal Procedure Name Package Code Amount Medical Management of Acute Severe Asthma With M1.1 51310 Acute Respiratory Failure Medical Management of COPD with Respiratory M1.2 82095 Failure (Infective Exacerbation) Medical Management of Acute Bronchitis with M1.3 61572 Pneumonia and Respiratory Failure M1.4 Medical Management of ARDS 102619 Medical Management of ARDS with Multi Organ M1.5 118013 failure (R65.1) Medical Management of ARDS with DIC (Blood and M1.6 143668 Blood Products) (D65) Medical Management of Poisioning Requiring M1.7 51310 Ventilatory Assistance M1.8 Intensive care management of Septic Shock 61572 Medical management of SLE (Systemic Lupus M10.1.1 26323 Erythematosis) Medical management of Sle (Systemic Lupus M10.1.2 73116 Erythematosis) with sepsis M10.2 Medical management of Scleroderma 30786 Medical management of Mctd Mixed Connective M10.3 25654 Tissue Disorder M10.4 Medical management of Primary Sjogren\'S Syndrome 20524 M10.5 Medical management of Vasculitis 30786 Medical management of Pyelonephritis in M11.1.1 22074 uncontrolled Diabetes melitus Medical management of Lower Respiratoy Tract M11.1.2 23603 Infection M11.1.3 Medical management of Fungal Sinusitis 42013 M11.1.4 Medical management of Cholecystitis 30479 Medical management of Cavernous Sinus Thrombosis M11.1.5 42085 in uncontrolled Diabetes melitus M11.1.6 Medical management of Rhinocerebral Mucormycosis 52973 Initial evaluation and management of Hypopituitarism M11.2.1 26681 with growth harmone M11.2.2 Hormonal therapy for Pituitary - Acromegaly 18923 M11.2.3 Medical Management of Cushings Syndrome 30787 Hormonal therapy for Delayed Puberty Hypogonadism- M11.2.4 14880 Turners Syndrome/Kleinfelter Syndrome(Q98.4) Hypopiturasim Initial Evaluation And Management M11.2.5 26681 With Growth Hormone Hypopiturasim Maintanance Phase Monthly Package M11.2.6 13915 For Growth Hormone M11.2.7 Medical Management of Graves Disease 10323 M12.1 Medical management of Corrosive Oesophageal Injury 21868 M12.10 Medical management of Acute Pancreatitis (Mild) 51310 M12.11 Medical management of Acute Pancreatitis (Severe) 153930 Conservative management of Acute Pancreatitis With M12.12 30785 Pseudocyst (Infected) Conservative management of Chronic Pancreatitis M12.13 30785 with Severe Pain M12.14 Conservative management of Obscure GI Bleed 51309 Conservative management of Cirrhosis with Hepatic M12.15 41048 Encephalopathy Medical management of Cirrhosis with Hepato Renal M12.16 41048 Syndrome M12.17.1 Medical management of Post op stent 48057 M12.17.2 Medical management of Post op leaks 48539 M12.17.3 Medical management of Sclerosing Cholangitis 76965 Medical Management of Cirrhosis Decompensated M12.18 37836 Including SBP, Portal HTN, Bleed Medical Management of Acute Hepatitis (Viral, M12.19 15392 Alcohol, Drugs, Misc. Infections) Conservative management of Oesophageal Foreign M12.2 8137 Body Medical Management of Ascities Of Any Etiology M12.20 15403 (Tubercolor, Melignant, Pancreatic, Biliary) M12.3 Conservative management of Oesophageal Perforation 51309 M12.4 Medical management of Achalasia Cardia 13638 Medical Management of Oesophageal Varices using M12.5 12509 Variceal Banding Medical Management of Oesophageal Varices with M12.6 10364 Sclerotherapy M12.7 Medical management of Oesophageal Fistula 30786 Medical management of GAVE(Gastric Antral M12.8 20524 Vascular Ectasia) M12.9 Medical management of Gastric Varices 15290 Medical Management of Thrombocytopenia With M2.1 30786 Bleeding Diathesis M2.2.1 Medical Management of Hemophilia (D67/D68.0) 61573 M2.2.2 Medical Management of Other Coagulation Disorders 45153 Medical Management of Chelation Therapy For M2.3 15393 Thalassemia Major M2.4 Medical Management of Cerebral Malaria 25655 M2.5 Medical Management of TB Meningitis 30787 Medical Management of Snake Bite Requiring M2.6 61572 Ventilator Support Medical Management of Scorpion Sting Requiring M2.7 25656 Ventilator Support Medical Management of Metabolic Coma Requiring M2.8 35917 Ventilatory Support M2.9 Medical Management of Dengue Haemorrhagic Fever 35917 M3.1 Medical Management of Severe Tetanus 28703 M3.2 Medical Management of Complicated Diphtheria 27502 M3.3 Medical Management of Cryptococcal Meningitis 30581 Medical management of term Baby With Septicemia M4.1.1 Culture Positive,Hyperbili rubinemia Not requiring 35917 Ventilatory support. Medical management of pre-term Baby of 30 To 32 M4.1.10 Weeks Septi cemia Ductus Arteriosus -requiring 61572 Mechanical Ventilation. Medical management of pre-term Baby of <30 Weeks Severe Hyaline Membrane Disease Septi cemia M4.1.11 92358 Culture Positive,Hyperbili rubinemia Patent Ductus Arteriosus -requiring Mechanical Ventilation. Medical Management of Term Baby With Persistent M4.1.12 Pulmonary Hypertension Ventilation-Hfo 51310 Hyperbilirubinem ia Clinically evident septicemia. Medical Management of Term Baby With Severe Perinatal Asphyxia Clinically evident septicemia, M4.1.13 35917 Hyperbilirubinem ia - Not requiring Ventilatory support. Medical Management of Term Baby With Severe M4.1.14 Perinatal Asphyxia Clinically evident septicemia, 51310 Hyperbilirubinemia - requiring Ventilatory support. Medical Management of Term Baby Severe M4.1.15 35917 Hyperbilirubinemia Clinically evident Septicemia. Medical management of Seizures in term baby M4.1.16 51310 requiring ventilatory support. Medical Management of Necrotising Enterocolitis, M4.1.17 Clinically evident Septicemia, Hyperbilirubinem ia not 35917 requiring ventilatory support. Medical Management of Term Baby, Fulminant septicemia Culture Positive with Septic Shock, M4.1.18 51310 Hyperbilirubinem ia Renal Failure requiring ventilatory support. Medical Management of Preterm Baby 33 To 34 Weeks with Severe Hyaline Membrane Disease M4.1.2 61572 Clinically evident septicemia Hyperbilirubinemia requiring Bubble Cpap. Medical Management of pre term baby of 33 To 34 Weeks with Severe Hyaline Membrane Disease M4.1.3 61572 Clinically evident septicemia Hyperbilirubinemia requiring ventilatory support. Medicalmanagement of Preterm baby of 35 To 36 Weeks with Mild Hyaline Membrane Disease M4.1.4 35917 septicemia Culture Positive Hyperbilirubinem ia not requiring ventilatory support. Medicalmanagement of Preterm baby of 33 To 34 Weeks with Mild Hyaline Membrane Disease M4.1.5 35917 septicemia Culture Positive Hyperbilirubinem ia not requiring ventilatory support. Medical management of Preterm baby of 33 To 34 Weeks with severe Hyaline Membrane Disease M4.1.6 61572 septicemia Culture Positive Hyperbilirubinem requiring ventilatory support/ bubble Cpap. Medical management of Preterm baby of 30 To 32 Weeks with severe Hyaline Membrane Disease M4.1.7 61572 septicemia Culture Positive Hyperbilirubinem ia requiring Mechanical ventilatory support. Medical management of Preterm baby of<30 Weeks with severe Hyaline Membrane Disease septicemia M4.1.8 92358 Culture PositiveHyperbilirubinem ia requiring Mechanical ventilatory support. Medical management of Preterm baby of 33 To 34 Weeks with severe Hyaline Membrane Disease M4.1.9 septicemia Culture Positive Hyperbilirubinem ia 61572 Patent Ductus Arteriosus- requiring Mechanical ventilatory support. Medical management of Severe Bronchiolitis(Non M4.2.1.1 15393 Ventilated) Medical Management of Severe M4.2.1.2 20524 Bronchiolitis(Ventilated) Medical Management of Severe Bronchopneumon M4.2.1.3 15393 ia(Non Ventilated) Medical Management of Severe Bronchopneumon M4.2.1.4 20524 ia(Ventilated) Medical Management of Acute Severe Asthma M4.2.1.5 20524 (Ventilated) Medical Management of Severe Aspiration Pneumonia M4.2.1.6 15393 (Non Ventilated) Medical Management of Severe Aspiration Pneumonia M4.2.1.7 20524 ( Ventilated) Medical Management of ARDS With Multi- Organ M4.2.1.8 118013 Failure Medical Management of ARDS Plus DIC (Blood and M4.2.1.9 143668 Blood Products) Medical Management of Severe Myocarditis in M4.2.2.1 41048 Paediatric patient Medical Management of Congenital Heart Disease M4.2.2.2 25655 With Infection (Non Ventilated) in Paediatric patient Medical Management of Congenital Heart Disease M4.2.2.3 With Infection And Cardiogenic Shock (Ventilated) in 51310 Paediatric patients Medical Management of Cardiogenic Shock in M4.2.2.4 51310 Paediatric patients M4.2.2.5 Medical Management of Infective Endocarditis 25654 Medical Management of Rheumatic heart disease in M4.2.2.6 15393 Paediatric patient Medical Management of Meningo- Encephalitis (Non M4.2.3.1 41048 Ventilated) Medical Management of Meningo- Encephalitis in M4.2.3.2 61572 Paediatric patients (Ventilated) M4.2.3.3 Medical Management of Status Epilepticus 22074 Medical Management of Febrile Seizures (Atypical- M4.2.3.4 25655 Mechanical Ventilated) in Paediatric patients Medical Management of Intra Cranial Bleed in M4.2.3.5 51310 Paediatric patient Medical Management of Acute Gastro Intestinal Bleed M4.2.4.1 25655 in Paediatric patients Medical management of Acute Pancreatitis (Mild) in M4.2.4.2 51310 pediatric patients Medical Management of Acute Hepatitis With Hepatic M4.2.4.3 51310 Encephalopathy in Paediatric patient M4.2.5.1 Medical Management of Acute Renal Failure 20524 Medical Management of Diabetic Ketoacidosis in M4.2.6.1 30786 Paediatric patient M4.2.7.1 Medical management of Septic shock 61572 Medical Management of Snake Bite Requiring M4.2.8.1 61572 Ventilatory Assistance Medical Management of Scorpion Sting With M4.2.8.2 Myocarditis And Cardiogenic Shock Requiring 41048 Ventilatory Assistance in Paediatric patients Medical
Recommended publications
  • Phalloplasty and Urethral

    Phalloplasty and Urethral

    plastol na og A y Golpanian et al., Anaplastology 2016, 5:2 Anaplastology DOI: 10.4172/2161-1173.1000159 ISSN: 2161-1173 Review Article Open Access Phalloplasty and Urethral (Re)construction: A Chronological Timeline Samuel Golpanian, Kenneth A Guler, Ling Tao, Priscila G Sanchez, Klara Sputova and Christopher J Salgado* Division of Plastic Surgery, DeWitt Daughtry Family, University of Miami, Miami, FL, USA Abstract Since the first penile reconstruction in 1936, various techniques of phalloplasty and urethroplasty have been developed. These advancements have paralleled those in the field of plastic and reconstructive surgery and offer a complex patient population the opportunity of restoration of cosmetic and psychosexual function. The continuous evolution of these methods has resulted in constant improvement of the surgical techniques in use today. Here, we aim to describe a historical overview of phalloplasty and urethral (re)construction. Keywords: Phalloplasty; Urethroplasty; Reconstruction; Transgen- gender reassignment over the next 40 years. Various fasciocutaneous der; Surgery and extended pedicle island flaps were also developed during this time. Nonetheless, they continued to have suboptimal functional and Introduction aesthetic results due to their significant limitations in sensory recovery Phalloplasty is a complex surgical task. Successful creation or primarily [10,13,14]. restoration of the penis must meet certain cosmetic and functional Throughout the 1970’s other innovations were introduced in the field thresholds. The ideal neophallus should be sensate, hairless, and similar of penile reconstruction. In 1971, Kaplan et al. [15] developed a method in color to the surrounding skin. It should have an inconspicuous scar, that provided sensation to the neophallus.
  • Curative Pelvic Exenteration for Recurrent Cervical Carcinoma in the Era of Concurrent Chemotherapy and Radiation Therapy

    Curative Pelvic Exenteration for Recurrent Cervical Carcinoma in the Era of Concurrent Chemotherapy and Radiation Therapy

    Available online at www.sciencedirect.com ScienceDirect EJSO xx (2015) 1e11 www.ejso.com Review Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review H. Sardain a,b, V. Lavoue a,b,c,*, M. Redpath d, N. Bertheuil b,e, F. Foucher a,J.Lev^eque a,b,c a CHU de Rennes, Gynecology Department, Tertiary Surgery Center, Teaching Hospital of Rennes, Hopital^ Sud, 16, Bd de Bulgarie, 35000 Rennes, France b Universite de Rennes, Faculty of Medicine, 2 Henry Guilloux, 35000 Rennes, France c INSERM, ER440, Oncogenesis, Stress and Signaling (OSS), Rennes, France d McGill University, Department of Pathology, Jewish General Hospital, Cote^ Sainte Catherine, Montreal, QC, Canada e CHU de Rennes, Department of Plastic, Reconstructive and Aesthetic Surgery, Tertiary Surgery Center, Teaching Hospital of Rennes, Hopital^ Sud, 16, Bd de Bulgarie, 35000 Rennes, France Accepted 26 March 2015 Available online --- Abstract Objective: Pelvic exenteration requires complete resection of the tumor with negative margins to be considered a curative surgery. The pur- pose of this review is to assess the optimal preoperative evaluation and surgical approach in patients with recurrent cervical cancer to in- crease the chances of achieving a curative surgery with decreased morbidity and mortality in the era of concurrent chemoradiotherapy. Methods: Review of English publications pertaining to cervical cancer within the last 25 years were included using PubMed and Cochrane Library searches. Results: Modern imaging (MRI and PET-CT) does not accurately identify local extension of microscopic disease and is inadequate for pre- operative planning of extent of resection.
  • Understanding Icd-10-Cm and Icd-10-Pcs 3Rd Edition Download Free

    Understanding Icd-10-Cm and Icd-10-Pcs 3Rd Edition Download Free

    UNDERSTANDING ICD-10-CM AND ICD-10-PCS 3RD EDITION DOWNLOAD FREE Mary Jo Bowie | 9781305446410 | | | | | International Classification of Diseases, (ICD-10-CM/PCS) Transition - Background Palmer B. Manual placenta removal. A: Understanding ICD-10-CM and ICD-10-PCS 3rd edition International Classification of Diseases ICD is a common framework and language to report, compile, use and compare health information. Psychoanalysis Adlerian therapy Analytical therapy Mentalization-based treatment Transference focused psychotherapy. Hysteroscopy Vacuum aspiration. Every code begins with an alpha character, which is indicative of the chapter to which the code is classified. Search Compliance Understanding BC, resilience standards and how to comply Follow these nine steps to first identify relevant business continuity and resilience standards and, second, launch a successful While many coders use ICD lookup software to help them, referring to an ICD code book is invaluable to build an understanding of the classification system. Pregnancy test Leopold's maneuvers Prenatal testing. Endoscopy : Colonoscopy Anoscopy Capsule endoscopy Enteroscopy Proctoscopy Sigmoidoscopy Abdominal ultrasonography Defecography Double-contrast barium enema Endoanal ultrasound Enteroclysis Lower gastrointestinal series Small-bowel follow-through Transrectal ultrasonography Virtual colonoscopy. Psychosurgery Lobotomy Bilateral cingulotomy Multiple subpial transection Hemispherectomy Corpus callosotomy Anterior temporal lobectomy. While codes in sections are structured similarly to the Medical and Surgical section, there are a few exceptions. Send Feedback Do you have Understanding ICD-10-CM and ICD-10-PCS 3rd edition on the new website? Help Learn to edit Community portal Recent changes Upload file. D Radiation oncology. Stem cell transplantation Hematopoietic stem cell transplantation. The primary distinctions are:. Palmer Joseph C.
  • ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain Infectious and Parasitic Diseases (A00-B99)

    ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain Infectious and Parasitic Diseases (A00-B99)

    ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain infectious and parasitic diseases (A00-B99) No Change Intestinal infectious diseases (A00-A09) No Change A04 Other bacterial intestinal infections No Change A04.7 Enterocolitis due to Clostridium difficile Add A04.71 Enterocolitis due to Clostridium difficile, recurrent Add A04.72 Enterocolitis due to Clostridium difficile, not specified as recurrent No Change A05 Other bacterial foodborne intoxications, not elsewhere classified No Change Excludes1: Revise from Clostridium difficile foodborne intoxication and infection (A04.7) Revise to Clostridium difficile foodborne intoxication and infection (A04.7-) No Change Helminthiases (B65-B83) No Change B81 Other intestinal helminthiases, not elsewhere classified No Change Excludes1: Revise from angiostrongyliasis due to Parastrongylus cantonensis (B83.2) Revise to angiostrongyliasis due to: Add Angiostrongylus cantonensis (B83.2) Add Parastrongylus cantonensis (B83.2) No Change B81.3 Intestinal angiostrongyliasis Revise from Angiostrongyliasis due to Parastrongylus costaricensis Revise to Angiostrongyliasis due to: Add Angiostrongylus costaricensis Add Parastrongylus costaricensis No Change Chapter 2 No Change Neoplasms (C00-D49) No Change Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80) No Change C79 Secondary malignant neoplasm of other and unspecified sites Delete Excludes2: lymph node metastases (C77.0) No Change C79.1 Secondary malignant neoplasm of bladder
  • Pelvic Exenteration for the Management of Pelvic Malignancies

    Pelvic Exenteration for the Management of Pelvic Malignancies

    Chapter 7 Pelvic Exenteration for the Management of Pelvic Malignancies Daniel Paramythiotis, Konstantinia Kofina and Antonios Michalopoulos Additional information is available at the end of the chapter http://dx.doi.org/10.5772/61083 Abstract Pelvic exenteration is a surgical procedure first described by Brunschwig in 1948 as a curative or palliative treatment for pelvic and perineal tumors. It is actually a radical operation, involving en bloc resection of pelvic organs, including reproductive structures, bladder, and rectosigmoid. In patients with recurrent cervical and vaginal malignancy, it is associated with a 5-year survival of more than 50%. In spite of advances in surgical management, consequences such as stomas, are still frequently unavoidable for radical tumor excision. Most candidates for this procedure have been diagnosed with recurrent cervical cancer that has previously been treated with surgery and radiation, or radiation alone. Complications of pelvic exenteration are more severe than those of standard resection of a colorectal carcinoma, so it is not commonly performed, including wound infection, wound dehiscence (also described as burst abdomen) the creation of fistulae (perineal-fecal, uretero-vaginal, between conduit and perineal wound), urinary tract infections, perineal hernias and intestinal obstruction. Patients need to be carefully selected and counseled about risks and long-term issues related to the surgery. A comprehensive evaluation is required in order to exclude unresectable or metastatic disease. Evolution of the technique through laparoscopy and minimally invasive surgery may result in a reduction of morbidity and mortality. Keywords: Pelvic exenteration, gynecologic cancer 1. Introduction Pelvic exenteration was first described by Brunschwig and his colleagues of New York’s Memorial Hospital in 1948 [1] and was initially performed as a palliative surgical intervention © 2015 The Author(s).
  • From Circumcision Injury to Penile Amputation

    From Circumcision Injury to Penile Amputation

    Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 375285, 6 pages http://dx.doi.org/10.1155/2014/375285 Review Article Traumatic Penile Injury: From Circumcision Injury to Penile Amputation Jae Heon Kim,1 Jae Young Park,2 and Yun Seob Song1 1 Department of Urology, Soonchunyang University Hospital, College of Medicine, Soonchunhyang University, Seoul, Republic of Korea 2 Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea Correspondence should be addressed to Jae Young Park; [email protected] and Yun Seob Song; [email protected] Received 24 April 2014; Revised 16 August 2014; Accepted 16 August 2014; Published 28 August 2014 Academic Editor: Ralf Herwig Copyright © 2014 Jae Heon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The treatment of external genitalia trauma is diverse according to the nature of trauma and injured anatomic site. The classification of trauma is important to establish a strategy of treatment; however, to date there has been less effort to make a classification for trauma of external genitalia. The classification of external trauma in male could be established by the nature of injury mechanism or anatomic site: accidental versus self-mutilation injury and penis versus penis plus scrotum or perineum. Accidental injury covers large portion of external genitalia trauma because of high prevalence and severity of this disease. The aim of this study is to summarize the mechanism and treatment of the traumatic injury of penis.
  • Treating Cervical Cancer If You've Been Diagnosed with Cervical Cancer, Your Cancer Care Team Will Talk with You About Treatment Options

    Treating Cervical Cancer If You've Been Diagnosed with Cervical Cancer, Your Cancer Care Team Will Talk with You About Treatment Options

    cancer.org | 1.800.227.2345 Treating Cervical Cancer If you've been diagnosed with cervical cancer, your cancer care team will talk with you about treatment options. In choosing your treatment plan, you and your cancer care team will also take into account your age, your overall health, and your personal preferences. How is cervical cancer treated? Common types of treatments for cervical cancer include: ● Surgery for Cervical Cancer ● Radiation Therapy for Cervical Cancer ● Chemotherapy for Cervical Cancer ● Targeted Therapy for Cervical Cancer ● Immunotherapy for Cervical Cancer Common treatment approaches Depending on the type and stage of your cancer, you may need more than one type of treatment. For the earliest stages of cervical cancer, either surgery or radiation combined with chemo may be used. For later stages, radiation combined with chemo is usually the main treatment. Chemo (by itself) is often used to treat advanced cervical cancer. ● Treatment Options for Cervical Cancer, by Stage Who treats cervical cancer? Doctors on your cancer treatment team may include: 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 ● A gynecologist: a doctor who treats diseases of the female reproductive system ● A gynecologic oncologist: a doctor who specializes in cancers of the female reproductive system who can perform surgery and prescribe chemotherapy and other medicines ● A radiation oncologist: a doctor who uses radiation to treat cancer ● A medical oncologist: a doctor who uses chemotherapy and other medicines to treat cancer Many other specialists may be involved in your care as well, including nurse practitioners, nurses, psychologists, social workers, rehabilitation specialists, and other health professionals.
  • Rectal Indomethacin Or I.V. Gabexate Mesylate As Prophylaxis for AP ERCP

    Rectal Indomethacin Or I.V. Gabexate Mesylate As Prophylaxis for AP ERCP

    European Review for Medical and Pharmacological Sciences 2017; 21: 5268-5274 Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography V. GUGLIELMI, M. TUTINO, V. GUERRA, P. GIORGIO National Institute of Gastroenterology, “S. de Bellis” Research Hospital Castellana Grotte, Bari, Italy Abstract. – OBJECTIVE: We aimed to evaluate mechanisms of AP are obstruction of the com- the results in our case series of AP ERCP over mon bile duct by stones, and alcohol abuse. En- the last three years. The prophylaxis for acute doscopic retrograde cholangiopancreatography pancreatitis (AP) post-endoscopic retrograde (ERCP) is the most frequent iatrogenic cause. cholangiopancreatography (ERCP) consists of rectal indomethacin, but some studies are not Post-ERCP AP is the most common and fear concordant. some adverse event for this procedure. In the PATIENTS AND METHODS: We compared 241 United States this complication costs $150 mil- ERCP performed from January 2014 to February lion annually for American Healthcare2,3 and it 2015 with intravenous gabexate mesylate (Group is a common cause of endoscopy-related lawsu- A), with the 387 ERCP performed from March its against gastroenterologists in the world. It 2015 to December 2016 with rectal indometha- has a significant morbidity and rare mortality cin (Group B) as prophylaxis for AP post-ERCP. RESULTS: There were 8 (3.31%) AP post-ERCP rate. About 10% of post-ERCP AP is moderate in Group A vs. 4 (1.03%) in Group B. or severe. Post-ERCP severe AP is associated CONCLUSIONS: Rectal indomethacin shows a with a higher mortality than non-ERCP-indu- better statistically significant performance than ced pancreatitis, but without statistical eviden- intravenous gabexate mesylate in the prophylax- ce4.
  • Eye Disease 1 Eye Disease

    Eye Disease 1 Eye Disease

    Eye disease 1 Eye disease Eye disease Classification and external resources [1] MeSH D005128 This is a partial list of human eye diseases and disorders. The World Health Organisation publishes a classification of known diseases and injuries called the International Statistical Classification of Diseases and Related Health Problems or ICD-10. This list uses that classification. H00-H59 Diseases of the eye and adnexa H00-H06 Disorders of eyelid, lacrimal system and orbit • (H00.0) Hordeolum ("stye" or "sty") — a bacterial infection of sebaceous glands of eyelashes • (H00.1) Chalazion — a cyst in the eyelid (usually upper eyelid) • (H01.0) Blepharitis — inflammation of eyelids and eyelashes; characterized by white flaky skin near the eyelashes • (H02.0) Entropion and trichiasis • (H02.1) Ectropion • (H02.2) Lagophthalmos • (H02.3) Blepharochalasis • (H02.4) Ptosis • (H02.6) Xanthelasma of eyelid • (H03.0*) Parasitic infestation of eyelid in diseases classified elsewhere • Dermatitis of eyelid due to Demodex species ( B88.0+ ) • Parasitic infestation of eyelid in: • leishmaniasis ( B55.-+ ) • loiasis ( B74.3+ ) • onchocerciasis ( B73+ ) • phthiriasis ( B85.3+ ) • (H03.1*) Involvement of eyelid in other infectious diseases classified elsewhere • Involvement of eyelid in: • herpesviral (herpes simplex) infection ( B00.5+ ) • leprosy ( A30.-+ ) • molluscum contagiosum ( B08.1+ ) • tuberculosis ( A18.4+ ) • yaws ( A66.-+ ) • zoster ( B02.3+ ) • (H03.8*) Involvement of eyelid in other diseases classified elsewhere • Involvement of eyelid in impetigo
  • Frey Operation for Chronic Pancreatitis Associated with Pancreas Divisum: Case Report and Review of the Literature

    Frey Operation for Chronic Pancreatitis Associated with Pancreas Divisum: Case Report and Review of the Literature

    Case report Frey operation for chronic pancreatitis associated with pancreas divisum: case report and review of the literature Magdalena Skórzewska1, Tomasz Romanowicz2, Jerzy Mielko1, Andrzej Kurylcio1, Jan Pertkiewicz3, Robert Zymon2, Wojciech P. Polkowski1 1Department of Surgical Oncology, Medical University of Lublin, Poland 2Department of General and Oncological Surgery, Pope John Paul II Regional Hospital, Zamosc, Poland 3Olympus Endotherapy, Warsaw, Poland Prz Gastroenterol 2014; 9 (3): 175–178 DOI: 10.5114/pg.2014.43581 Key words: pancreas divisum, chronic pancreatitis, surgery. Address for correspondence: Prof. Wojciech P. Polkowski MD, PhD, Department of Surgical Oncology, Medical University of Lublin, 11 Staszica St, 20-081 Lublin, Poland, phone: +48 81 534 43 13, fax: +48 81 532 23 95, e-mail: [email protected] Abstract Pancreas divisum (PD) is the most common congenital anomaly of the pancreas, which increases susceptibility to recurrent pancreatitis. Usually, after failure of initial endoscopic therapies, surgical treatment combining pancreatic resection or drainage is used. The Frey procedure is used for chronic pancreatitis, but it has not been reported to be applied in an adult patient with PD-associated pancreatitis. The purpose of the paper was to describe effective treatment of this rare condition by the Frey procedure after failure of interventional endoscopic treatment. A 39-year-old female patient was initially treated for recurrent acute pancreatitis. After endoscopic diagnosis of PD, the minor duodenal papilla was incised and a plastic stent was inserted into the dorsal pancreatic duct. During the following 36 months, the patient was hospitalised several times because of recur- rent episodes of pancreatitis. Thereafter, local resection of the pancreatic head combined with lateral pancreaticojejunostomy was performed with no complications.
  • Once in a Lifetime Procedures Code List 2019 Effective: 11/14/2010

    Once in a Lifetime Procedures Code List 2019 Effective: 11/14/2010

    Policy Name: Once in a Lifetime Procedures Once in a Lifetime Procedures Code List 2019 Effective: 11/14/2010 Family Rhinectomy Code Description 30160 Rhinectomy; total Family Laryngectomy Code Description 31360 Laryngectomy; total, without radical neck dissection 31365 Laryngectomy; total, with radical neck dissection Family Pneumonectomy Code Description 32440 Removal of lung, pneumonectomy; Removal of lung, pneumonectomy; with resection of segment of trachea followed by 32442 broncho-tracheal anastomosis (sleeve pneumonectomy) 32445 Removal of lung, pneumonectomy; extrapleural Family Splenectomy Code Description 38100 Splenectomy; total (separate procedure) Splenectomy; total, en bloc for extensive disease, in conjunction with other procedure (List 38102 in addition to code for primary procedure) Family Glossectomy Code Description Glossectomy; complete or total, with or without tracheostomy, without radical neck 41140 dissection Glossectomy; complete or total, with or without tracheostomy, with unilateral radical neck 41145 dissection Family Uvulectomy Code Description 42140 Uvulectomy, excision of uvula Family Gastrectomy Code Description 43620 Gastrectomy, total; with esophagoenterostomy 43621 Gastrectomy, total; with Roux-en-Y reconstruction 43622 Gastrectomy, total; with formation of intestinal pouch, any type Family Colectomy Code Description 44150 Colectomy, total, abdominal, without proctectomy; with ileostomy or ileoproctostomy 44151 Colectomy, total, abdominal, without proctectomy; with continent ileostomy 44155 Colectomy,
  • A Gastric Duplication Cyst with an Accessory Pancreatic Lobe

    A Gastric Duplication Cyst with an Accessory Pancreatic Lobe

    Turk J Gastroenterol 2014; 25 (Suppl.-1): 199-202 An unusual cause of recurrent pancreatitis: A gastric duplication cyst with an accessory pancreatic lobe xxxxxxxxxxxxxxx Aysel Türkvatan1, Ayşe Erden2, Mehmet Akif Türkoğlu3, Erdal Birol Bostancı3, Selçuk Dişibeyaz4, Erkan Parlak4 1Department of Radiology, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey 2Department of Radiology, Ankara University Faculty of Medicine, Ankara, Turkey 3Department of Gastroenterological Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey 4Department of Gastroenterology, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey ABSTRACT Congenital anomalies of pancreas and its ductal drainage are uncommon but in general surgically correctable causes of recurrent pancreatitis. A gastric duplication cyst communicated with an accessory pancreatic lobe is an extremely rare cause of recurrent pancreatitis, but an early and accurate diagnosis of this anomaly is important because suitable surgical treatment may lead to a satisfactory outcome. Herein, we presented multidetector com- puted tomography and magnetic resonance imaging findings of a gastric duplication cyst communicating with an accessory pancreatic lobe via an aberrant duct in a 29-year-old woman with recurrent acute pancreatitis and also reviewed other similar cases reported in the literature. Keywords: Aberrant pancreatic duct, accessory pancreatic lobe, acute pancreatitis, gastric duplication cyst, multi- detector computed tomography, magnetic resonance imaging INTRODUCTION Herein, we presented multidetector CT and MRI find- Report Case Congenital causes of recurrent pancreatitis include ings of a gastric duplication cyst communicating with anomalies of the biliary or pancreatic ducts, espe- an accessory pancreatic lobe via an aberrant duct in a cially pancreas divisum. A gastric duplication cyst 29-year-old woman with recurrent acute pancreatitis communicating with an aberrant pancreatic duct is and also reviewed other similar cases reported in the an extremely rare but curable cause of recurrent pan- literature.